What should be included in the orders when prescribing regular insulin for a patient with potential impaired renal function and other underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ordering Regular Insulin: Essential Components for Safe Administration

When ordering regular insulin for a patient, you must specify the dose, frequency, timing relative to meals (30-45 minutes before), blood glucose monitoring schedule, correction scale parameters, and hypoglycemia management protocols. 1, 2, 3

Core Order Components

1. Insulin Regimen Structure

  • Never order sliding scale insulin as monotherapy – this approach is explicitly condemned by all major diabetes guidelines and leads to dangerous glucose fluctuations 1, 2, 3
  • Order a scheduled basal-bolus regimen with basal insulin (50% of total daily dose) plus regular insulin before meals (remaining 50% divided among three meals) 1, 3
  • For hospitalized patients who are insulin-naive, start with 0.3-0.5 units/kg/day total daily dose, with half as basal insulin 3

2. Regular Insulin Dosing and Timing

  • Administer regular insulin 30-45 minutes before meals – this is critical as regular insulin has a slower onset than rapid-acting analogs 3, 4
  • For prandial coverage, start with 4 units before the largest meal or use 10% of the basal dose 2, 3
  • Titrate by 1-2 units every 3 days based on 2-hour postprandial glucose readings 2, 3

3. Blood Glucose Monitoring Requirements

  • Order bedside glucose monitoring before each meal and at bedtime for patients eating regular meals 1, 3
  • For patients not eating (NPO), order glucose checks every 4-6 hours 1, 3
  • Daily fasting blood glucose monitoring is essential during titration 2, 3

4. Target Glucose Ranges

  • Fasting glucose target: 80-130 mg/dL 1, 2, 3
  • Postprandial glucose target: <180 mg/dL 1, 3
  • For hospitalized patients, target glucose range is 140-180 mg/dL for the majority of critically ill and non-critically ill patients 1

5. Correction Insulin Protocol

  • Add correction doses using regular insulin for premeal glucose >180 mg/dL, separate from scheduled doses 3
  • Use simplified sliding scale as adjunct only: 2 units for glucose >250 mg/dL, 4 units for glucose >350 mg/dL 3
  • Never give regular insulin at bedtime to avoid nocturnal hypoglycemia 3

6. Special Considerations for Renal Impairment

  • For patients with history of hypoglycemia and potential renal impairment, start with conservative basal insulin dose of 0.1 units/kg/day 2
  • For eGFR <45 mL/min/1.73 m², titrate conservatively to avoid hypoglycemia 2, 3
  • For CKD Stage 5, reduce total daily insulin dose by 50% for type 2 diabetes or 35-40% for type 1 diabetes 2, 3

7. Hypoglycemia Management Orders

  • Order glucagon for emergent hypoglycemia 2
  • Specify treatment protocol: 15 grams of fast-acting carbohydrate for blood glucose ≤70 mg/dL 2, 3
  • If hypoglycemia occurs without clear cause, immediately reduce dose by 10-20% 2, 3

8. Foundation Therapy

  • Continue metformin unless contraindicated (eGFR <30 mL/min/1.73 m²) 2, 3
  • Metformin reduces total insulin requirements and provides complementary glucose-lowering effects 2, 3

9. Titration Instructions

  • For fasting glucose 140-179 mg/dL: increase basal insulin by 2 units every 3 days 2, 3
  • For fasting glucose ≥180 mg/dL: increase basal insulin by 4 units every 3 days 2, 3
  • For high-risk patients (elderly >65 years, renal impairment, history of hypoglycemia), use maximum 2-unit increments every 3 days 2

10. Critical Threshold Warning

  • When basal insulin exceeds 0.5 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone 2, 3
  • Signs of overbasalization include: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, and high glucose variability 2, 3

Common Pitfalls to Avoid

  • Do not use standard starting doses (0.2 units/kg/day) in high-risk patients with history of hypoglycemia or renal impairment 2
  • Do not delay dose reduction when hypoglycemia occurs – 75% of hospitalized patients who experienced hypoglycemia had no insulin dose adjustment before the next administration 3
  • Do not rely solely on sliding scale adjustments – scheduled insulin doses must be adjusted based on patterns 3
  • Do not give rapid-acting or regular insulin at bedtime as this increases nocturnal hypoglycemia risk 3

Administration and Storage

  • Regular insulin should not be diluted or mixed with other insulin preparations 5
  • Insulin is not intended for intravenous or intramuscular administration when ordering subcutaneous regular insulin 5
  • Continuous rotation of injection sites within a given area helps reduce lipodystrophy 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy in Patients with Hypoglycemia History and Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.